نتائج البحث - "Robert Cuddihy"

المساهمون: Yazıcı, Dilek, Marso, S. P., Daniels, G. H, Brown-Frandsen, K., Kristensen, P., Mann, J, F., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M, Buse, J. B., LEADER Steering Committee, LEADER Trial Investigators, School of Medicine, Department of Endocrinology, Diabetes and Metabolism Diseases, Marso, S., Daniels, G., Frandsen, K., Mann, J., Nauck, M., Nissen, S., Poulter, N., Ravn, L., Steinberg, W., Bergenstal, R., Buse, J., Bergenstal R, Buse J, Daniels G, Mann J, O, Buscemi, S., et al, Marso, Steven P., Daniels, Gilbert H., Kirstine Brown Frandsen, Peter, Kristensen, Mann, Johannes F. E., Nauck, Michael A., Nissen, Steven E., Stuart, Pocock, Poulter, Neil R., Ravn, Lasse S., Steinberg, William M., Mette, Stockner, Bernard, Zinman, Bergenstal, Richard M., Buse, John B., for the LEADER Steering Committee on behalf of the LEADER Trial Investigators [Study Investigator:, . . ., Gambineri, Alessandra, Repaci, Andrea, Ribichini, Danilo, ], . ., National Institute for Health Research, Imperial College Healthcare NHS Trust- BRC Funding

المصدر: New England Journal of Medicine
Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827

مصطلحات موضوعية: Male, Gastrointestinal Diseases, Treatment outcome, Clinical Biochemistry, Myocardial Infarction, Type 2 diabetes, 030204 cardiovascular system & hematology, law.invention, Medicine, Endocrinology, 0302 clinical medicine, Randomized controlled trial, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Humans, Hypoglycemic Agents, Liraglutide, Middle Aged, Stroke, Treatment Outcome, Medicine (all), law, Cardiovascular Disease, Clinical-trial, Pancreatitis, Therapies, Cancer, Drugs, 11 Medical and Health Sciences, Research Support, Non-U.S. Gov't, PANCREATITIS, Hazard ratio, LEADER Steering Committee, Follow up studies, General Medicine, Albiglutide, Multicenter Study, TRIALS, Randomized Controlled Trial, Life Sciences & Biomedicine, Cardiovascular outcomes, medicine.drug, Human, medicine.medical_specialty, Gastrointestinal Disease, MEDLINE, 030209 endocrinology & metabolism, LEADER Trial Investigators, Placebo, Follow-Up Studie, 03 medical and health sciences, Medicine, General & Internal, Research Support, N.I.H., Extramural, General & Internal Medicine, Diabetes mellitus, Internal medicine, medicine, Journal Article, Glycemic efficacy, Science & Technology, Hypoglycemic Agent, business.industry, Semaglutide, medicine.disease, Surgery, business, Follow-Up Studies